Details for New Drug Application (NDA): 212360
✉ Email this page to a colleague
The generic ingredient in TRANEXAMIC ACID is tranexamic acid. There are eight drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the tranexamic acid profile page.
Summary for 212360
Tradename: | TRANEXAMIC ACID |
Applicant: | Caplin |
Ingredient: | tranexamic acid |
Patents: | 0 |
Pharmacology for NDA: 212360
Physiological Effect | Decreased Fibrinolysis |
Medical Subject Heading (MeSH) Categories for 212360
Suppliers and Packaging for NDA: 212360
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TRANEXAMIC ACID | tranexamic acid | INJECTABLE;INJECTION | 212360 | ANDA | Baxter Healthcare Corporation | 43066-008 | 43066-008-10 | 10 CARTON in 1 BOX (43066-008-10) / 1 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSE (43066-008-01) |
TRANEXAMIC ACID | tranexamic acid | INJECTABLE;INJECTION | 212360 | ANDA | Caplin Steriles Limited | 65145-106 | 65145-106-10 | 10 VIAL in 1 BOX (65145-106-10) / 10 mL in 1 VIAL (65145-106-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 100MG/ML | ||||
Approval Date: | Jul 17, 2019 | TE: | AP | RLD: | No |
Complete Access Available with Subscription